| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
2e-07 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
3e-07 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-07 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-06 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-06 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
| mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
3e-05 |
| mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
5e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
7e-05 |